Protein misfolding, functional amyloid, and human disease; Protein folding and misfolding; Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases; Protein misfolding, evolution and disease; The amyloid state and its association with protein misfolding diseases; Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade; Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution; Designing conditions for in vitro formation of amyloid protofilaments and fibrils; Proliferation of amyloid-Î²42 aggregates occurs through a secondary nucleation mechanism; Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis; Rationalization of the effects of mutations on peptide andprotein aggregation rates; Principles of protein folding, misfolding and aggregation; Chemical space and biology.; An analytical solution to the kinetics of breakable filament assembly; The structural basis of protein folding and its links with human disease; Protein folding: a perspective from theory and experiment; Hydrodynamic radii of native and denatured proteins measured by pulse field gradient NMR techniques; The protofilament structure of insulin amyloid fibrils; Amyloid fibrils from muscle myoglobin; Amyloid formation by globular proteins under native conditions
